Clinical Trials Browser

Recruiting × Base Sequence × Gastrointestinal × Clear all

NCT06648057 2026-03-18

Investigation of Predictive Biomarkers in Patients With Advanced BTC Treated With Lenvatinib Plus Pembrolizumab

Gastrointestinal

Biliary Tract Neoplasms, Cholangiocarcinoma